临床正常成人中病理与体积生物标志物变化与认知下降的关联
在哈佛衰老脑研究的283名无痴呆或明显认知损害的老年人中,分析128名有纵向影像和认知数据的临床正常老年人,发现海马体积萎缩速度与认知下降相关(R2=0.28,p<0.0001),且独立于Aβ和tau,独特解释10%的方差;结合多种影像生物标志物变化可解释45%的认知下降方差。
要点
- 海马体积萎缩越快,认知下降越快(R2=0.28,p<0.0001)。
- 海马体积斜率独立于Aβ和tau与认知下降相关,独特解释10%方差。
- 结合不同影像生物标志物变化可解释45%的认知下降方差。
核心结论
- 在老年人中,纵向海马萎缩与认知下降相关,且独立于Aβ或tau,提示非AD病理(如TDP-43、血管性)可能参与海马介导的认知下降。
研究设计与样本
- 前瞻性队列研究,纳入哈佛衰老脑研究中283名无痴呆或明显认知损害的老年人,本报告仅分析有纵向影像和认知数据的128名临床正常老年人。
主要发现
- 纳入分析的128名临床正常老年人中,72名(56%)为女性,56名(44%)为男性;入组时中位年龄73岁(范围63-87)。
- 34名参与者(27%)在PET成像上显示初始高Aβ负荷。
- 海马体积萎缩越快与认知下降越快相关(R2=0.28,p<0.0001)。
- 比较所有生物标志物时,海马体积斜率独立于Aβ和tau测量与认知下降相关,独特解释10%的方差。
- 结合不同影像生物标志物的变化测量,共解释认知下降方差的45%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Hippocampal volume (HV) atrophy is a well-known biomarker of memory impairment. However, compared with β-amyloid (Aβ) and tau imaging, it is less specific for Alzheimer disease (AD) pathology. This lack of specificity could provide indirect information about potential copathologies that cannot be observed in vivo. In this prospective cohort study, we aimed to assess the associations among Aβ, tau, HV, and cognition, measured over a 10-year follow-up period with a special focus on the contributions of HV atrophy to cognition after adjusting for Aβ and tau. METHODS: We enrolled 283 older adults without dementia or overt cognitive impairment in the Harvard Aging Brain Study. In this report, we only analyzed data from individuals with available longitudinal imaging and cognition data. Serial MRI (follow-up duration 1.3-7.0 years), neocortical Aβ imaging on Pittsburgh Compound B PET scans (1.9-8.5 years), entorhinal and inferior temporal tau on flortaucipir PET scans (0.8-6.0 years), and the Preclinical Alzheimer Cognitive Composite (3.0-9.8 years) were prospectively collected. We evaluated the longitudinal associations between Aβ, tau, volume, and cognition data and investigated sequential models to test the contribution of each biomarker to cognitive decline. RESULTS: We analyzed data from 128 clinically normal older adults, including 72 (56%) women and 56 (44%) men; median age at inclusion was 73 years (range 63-87). Thirty-four participants (27%) exhibited an initial high-Aβ burden on PET imaging. Faster HV atrophy was correlated with faster cognitive decline (R2 = 0.28, p < 0.0001). When comparing all biomarkers, HV slope was associated with cognitive decline independently of Aβ and tau measures, uniquely accounting for 10% of the variance. Altogether, 45% of the variance in cognitive decline was explained by combining the change measures in the different imaging biomarkers. DISCUSSION: In older adults, longitudinal hippocampal atrophy is associated with cognitive decline, independently of Aβ or tau, suggesting that non-AD pathologies (e.g., TDP-43, vascular) may contribute to hippocampal-mediated cognitive decline. Serial HV measures, in addition to AD-specific biomarkers, may help evaluate the contribution of non-AD pathologies that cannot be measured otherwise in vivo.
引用
- Hanseeuw BJ, Jacobs HIL, Schultz AP, et al. Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults. Neurology. 2023. PMID: 37968130. doi:10.1212/WNL.0000000000207962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。